AU1276399A - Neuronal uses of bmp-11 - Google Patents

Neuronal uses of bmp-11

Info

Publication number
AU1276399A
AU1276399A AU12763/99A AU1276399A AU1276399A AU 1276399 A AU1276399 A AU 1276399A AU 12763/99 A AU12763/99 A AU 12763/99A AU 1276399 A AU1276399 A AU 1276399A AU 1276399 A AU1276399 A AU 1276399A
Authority
AU
Australia
Prior art keywords
proteins
bmp
neuronal
useful
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU12763/99A
Other languages
English (en)
Inventor
Anthony J. Celeste
Scott R Thies
John M. Wozney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of AU1276399A publication Critical patent/AU1276399A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU12763/99A 1997-11-07 1998-10-23 Neuronal uses of bmp-11 Withdrawn AU1276399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96629797A 1997-11-07 1997-11-07
US08966297 1997-11-07
PCT/US1998/022574 WO1999024057A2 (en) 1997-11-07 1998-10-23 Neuronal uses of bmp-11

Publications (1)

Publication Number Publication Date
AU1276399A true AU1276399A (en) 1999-05-31

Family

ID=25511184

Family Applications (2)

Application Number Title Priority Date Filing Date
AU12763/99A Withdrawn AU1276399A (en) 1997-11-07 1998-10-23 Neuronal uses of bmp-11
AU13900/99A Ceased AU761940B2 (en) 1997-07-29 1998-11-06 Neuronal uses of BMP-11

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU13900/99A Ceased AU761940B2 (en) 1997-07-29 1998-11-06 Neuronal uses of BMP-11

Country Status (10)

Country Link
EP (1) EP1028744B1 (enExample)
JP (1) JP2001522810A (enExample)
AT (1) ATE259652T1 (enExample)
AU (2) AU1276399A (enExample)
CA (1) CA2309538A1 (enExample)
DE (1) DE69821793T2 (enExample)
DK (1) DK1028744T3 (enExample)
ES (1) ES2213927T3 (enExample)
PT (1) PT1028744E (enExample)
WO (2) WO1999024057A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104977A1 (en) * 2000-03-31 2003-06-05 Ugo Ripamonti Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
TW200526779A (en) 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
US20040259779A1 (en) * 2001-07-06 2004-12-23 Teit Johansen Novel neurotrophic factors
US7320789B2 (en) 2001-09-26 2008-01-22 Wyeth Antibody inhibitors of GDF-8 and uses thereof
JP4429728B2 (ja) 2002-02-21 2010-03-10 ワイス エルエルシー フォリスタチン（ｆｏｌｌｉｓｔａｔｉｎ）ドメイン含有タンパク質
JP4429729B2 (ja) 2002-02-21 2010-03-10 ワイス エルエルシー Ｇａｓｐ１；フォリスタチンドメイン含有タンパク質
AR047392A1 (es) 2002-10-22 2006-01-18 Wyeth Corp Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
WO2004078211A1 (ja) * 2003-03-04 2004-09-16 Tanabe Seiyaku Co., Ltd. 粉末経鼻投与製剤
JP5110877B2 (ja) 2003-06-02 2012-12-26 ワイス・エルエルシー 神経筋障害を処置するための、コルチコステロイドと組み合わせたミオスタチン（ｇｄｆ８）インヒビターの使用
KR101135220B1 (ko) 2005-10-06 2012-04-24 일라이 릴리 앤드 캄파니 항-마이오스타틴 항체
UA92504C2 (en) 2005-10-12 2010-11-10 Эли Лилли Энд Компани Anti-myostatin monoclonal antibody
BRPI0716249A2 (pt) 2006-09-05 2013-09-03 Lilly Co Eli anticorpos antimiostatina
EP2983694B1 (en) 2013-04-08 2022-06-22 President and Fellows of Harvard College Compositions for rejuvenating skeletal muscle stem cells
WO2014201143A1 (en) * 2013-06-11 2014-12-18 President And Fellows Of Harvard College Methods and compositions for increasing neurogenesis and angiogenesis
WO2015070076A2 (en) * 2013-11-08 2015-05-14 President And Fellows Of Harvard College Methods and compositions for rejuvenating neuromuscular junctions
IL293766B2 (en) 2016-01-06 2023-08-01 Harvard College Treatment with gdf11 prevents weight gain, improves glucose loading and reduces hepatosteatosis
WO2019144053A1 (en) * 2018-01-19 2019-07-25 President And Fellows Of Harward College Gdf11 variants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2213745T3 (es) * 1993-05-12 2004-09-01 Genetics Institute, Llc Composiciones de bmp-11.
SE9302550D0 (sv) * 1993-07-30 1993-07-30 Ernst Hoerlin Powder inhaler
DE69434739T2 (de) * 1993-08-26 2007-05-10 Genetics Institute, LLC, Cambridge Menschliche Knochen-morphogenetische Proteine zur Verwendung bei neuronaler Rehgeneration
ATE305036T1 (de) * 1994-07-08 2005-10-15 Univ Johns Hopkins Med Wachstums-differenzierungsfaktor-11

Also Published As

Publication number Publication date
ES2213927T3 (es) 2004-09-01
CA2309538A1 (en) 1999-05-20
WO1999024058A3 (en) 1999-08-19
DK1028744T3 (da) 2004-06-21
ATE259652T1 (de) 2004-03-15
AU761940B2 (en) 2003-06-12
DE69821793D1 (de) 2004-03-25
AU1390099A (en) 1999-05-31
WO1999024058A2 (en) 1999-05-20
PT1028744E (pt) 2004-06-30
DE69821793T2 (de) 2004-12-30
EP1028744B1 (en) 2004-02-18
WO1999024057A2 (en) 1999-05-20
JP2001522810A (ja) 2001-11-20
EP1028744A2 (en) 2000-08-23

Similar Documents

Publication Publication Date Title
CA2161808A1 (en) Bmp-11 compositions
AU1276399A (en) Neuronal uses of bmp-11
ATE265529T1 (de) Bmp-10 zusammensetzungen
CA2030518A1 (en) Osteoinductive compositions
EP1230930A3 (en) Bmp-9 compositions
IL112873A0 (en) Rapamycin-fkbp12 binding proteins their isolation and their use
AU4165797A (en) Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
EP1719531A3 (en) Osteogenic devices and methods of use thereof for repair of bones
WO1999029718A3 (en) Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
DE69726884D1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
MX9602977A (es) Proteinas que reparan la mala union de adn humano.
IL125771A0 (en) Recombinant ribonuclease proteins
IL122606A (en) (S)-hydroxa-nitrile-lyase
AU3711597A (en) A novel galanin receptor
AUPM772494A0 (en) Improvements in production of proteins in host cells
AU4312093A (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
WO1994016085A3 (en) Hybrid proteins having cross-linking and tissue-binding activities
GB2374871A (en) Peptide fragments of colostrinin and their use
NZ334762A (en) Human DNase I variants having binding affinity to actin
MX9800507A (es) Ctla-8 humana y usos de proteinas relacionadas con la ctla-8.
UA32147A (uk) Спосіб профілактики вторинних деформацій носа при вроджених та набутих незрощеннях верхньої губи
AU5246598A (en) Methods and compositions for the treatment of bone resorption disorders, including osteoporosis